Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Jansson · SciRah

Researcher profile · Semantic Scholar

M. Jansson

Share profile

M. Jansson — researcher profile on SciRah

h-index: 13
Works: 26
Citations: 2,290

Most-cited papers

PD‐L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD‐L1 IHC Assay Comparison Project
F. Hirsch, A. McElhinny, D. Stanforth, J. Ranger-Moore +18 more
2017Journal of Thoracic Oncology1,229 citations Open access
Semantic Scholar
Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer
C. Roach, Nancy S Zhang, Ellie Corigliano, M. Jansson +6 more
2016Applied immunohistochemistry & molecular morphology (Print)303 citations Open access
Semantic Scholar
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
M. Pang, Anna-Maria Georgoudaki, L. Lambut, J. Johansson +11 more
2015Oncogene273 citations Open access
Semantic Scholar
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
J. Johansson, T. Berg, E. Kurzejamska, M. Pang +7 more
2013Oncogene163 citations Open access
Semantic Scholar
Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1.
M. Dolled-Filhart, C. Roach, Grant Toland, D. Stanforth +4 more
2016Archives of Pathology & Laboratory Medicine110 citations Open access
Semantic Scholar
Type IV collagen as a potential biomarker of metastatic breast cancer
M. Lindgren, M. Jansson, B. Tavelin, L. Dirix +2 more
2021Clinical and Experimental Metastasis37 citations Open access
Semantic Scholar
Trends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among men
J. Lyth, H. Eriksson, J. Hansson, C. Ingvar +8 more
2015British Journal of Dermatology35 citations Open access
Semantic Scholar
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma
Therese Phillips, Molly M. Millett, Xiao-Ling Zhang, M. Jansson +13 more
2017Applied immunohistochemistry & molecular morphology (Print)24 citations Open access
Semantic Scholar
Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)
Y. Mahamat-Saleh, Marie Al-Rahmoun, G. Severi, R. Ghiasvand +33 more
2022International Journal of Cancer23 citations Open access
Semantic Scholar
Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers
M. Jansson, Jessica A. Lindberg, Gunilla Rask, J. Svensson +5 more
2022Frontiers in Molecular Biosciences23 citations Open access
Semantic Scholar
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling
M. Jansson, Ola Billing, Carl Herdenberg, C. Lundin +3 more
2020Journal of mammary gland biology and neoplasia16 citations Open access
Semantic Scholar
1059PPD-L1 Detection and Assay Performance in Squamous Cell Carcinoma of the Head and Neck Using PD-L1 IHC 28-8 pharmDx
S. Álvarez, Joel A. Chan, J. William, C. Felten +15 more
201715 citations Open access
Semantic Scholar
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
Y. Naeser, H. Helgadottir, Y. Brandberg, J. Hansson +16 more
2020BMC Cancer13 citations Open access
Semantic Scholar
Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Head and Neck Squamous Cell Carcinoma
Christopher J. La Placa, Monika Vilardo, Brittany Watts, Monika D. Polewski +8 more
20217 citations Open access
Semantic Scholar
Surgery of metastatic melanoma after systemic therapy – the SUMMIST trial: study protocol for a randomized controlled trial
C. Holmberg, D. Katsarelias, H. Jespersen, A. Carneiro +8 more
2020Acta oncologica7 citations Open access
Semantic Scholar
Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study
Gunilla Rask, A. Nazemroaya, M. Jansson, C. Wadsten +5 more
2021Breast Cancer Research and Treatment6 citations Open access
Semantic Scholar
PD-L1 IHC 22C3 pharmdx demonstrates precision and reproducibility in detecting PD-L1 expression in triple negative breast cancer.
Karina Kulangara, Brittany Watts, Monika Vilardo, Christopher La Placa +4 more
2020Journal of Clinical Oncology3 citations
Semantic Scholar
Assay performance of the PD-L1 IHC 28-8 pharmDx assay in squamous cell carcinoma of the head and neck (SCCHN).
S. Álvarez, D. Hanks, J. William, Joel A. Chan +16 more
20172 citations
Semantic Scholar
PD-L1 IHC 22C3 pharmDx Demonstrates Precision and Reproducibility in Triple-negative Breast Cancer
Brittany Watts, Monika Vilardo, Christopher J. La Placa, J. Frederick +7 more
2023Journal of Cancer Treatment and Diagnosis1 citations Open access
Semantic Scholar
Development of a clinical trial immunohistochemistry (IHC) assay using a novel antibody to CD38.
K. Wakamiya, M. Hudson, Hayley Finkelstein, M. Nguyen +8 more
20171 citations
Semantic Scholar
Development of a diagnostic PD-L1 immunohistochemical assay for nivolumab therapy in urothelial carcinoma.
R. De los Santos, J. William, D. Hanks, A. Northrup +16 more
20171 citations
Semantic Scholar
Development of a clinical trial assay for PD-L1 immunohistochemistry (IHC) for use with pembrolizumab (pembro) clinical trials in melanoma.
M. Dolled-Filhart, S. Ebbinghaus, C. Roach, G. Ponto +3 more
20161 citations
Semantic Scholar
190. Expression and circulating levels of perlecan in breast cancer
M. Jansson, D. Öhlund, M. Sund
20141 citations
Semantic Scholar
Prognostic value of type IV collagen expression in early breast cancer.
M. Jansson, Gunilla Rask, A. Nazemroaya, M. Sund
2022European Journal of Surgical Oncology0 citations
Semantic Scholar
Type IV Collagen- A Potential Biomarker for Colorectal- and Breast Cancer Patients with Metastatic Disease
M. Lindgren, M. Jansson, I. Ljuslinder, Hanna Nyström
20200 citations
Semantic Scholar
Development of an immunohistochemistry assay for PD-L1 for using the 22C3 antibody in melanoma.
C. Roach, Jeanette Musser, G. Ponto, Grant Toland +5 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Sund×7
Invite
M. Sund — researcher profile on SciRah
Karina Kulangara×6
Invite
Karina Kulangara — researcher profile on SciRah
K. Emancipator×6
Invite
K. Emancipator — researcher profile on SciRah
D. Hanks×5
Invite
D. Hanks — researcher profile on SciRah

×5

Invite

J. William — researcher profile on SciRah

Invite

E. Oroudjev — researcher profile on SciRah

D. Stanforth×4

Invite

D. Stanforth — researcher profile on SciRah

Invite

J. Novotny — researcher profile on SciRah

Invite

C. Roach — researcher profile on SciRah

Grant Toland×4

Invite

Grant Toland — researcher profile on SciRah

Invite

G. Ponto — researcher profile on SciRah

M. Dolled-Filhart×4

Invite

M. Dolled-Filhart — researcher profile on SciRah